138 related articles for article (PubMed ID: 12948027)
21. Investigation of polymer and nanoparticle properties with nicotinic acid and p-aminobenzoic acid grafted on poly(ε-caprolactone)-poly(ethylene glycol)-poly(ε-caprolactone) via click chemistry.
Suksiriworapong J; Sripha K; Kreuter J; Junyaprasert VB
Bioconjug Chem; 2011 Apr; 22(4):582-94. PubMed ID: 21375231
[TBL] [Abstract][Full Text] [Related]
22. Preparation, drug release and cellular uptake of doxorubicin-loaded dextran-b-poly(ɛ-caprolactone) nanoparticles.
Li B; Wang Q; Wang X; Wang C; Jiang X
Carbohydr Polym; 2013 Apr; 93(2):430-7. PubMed ID: 23499079
[TBL] [Abstract][Full Text] [Related]
23. Design of ciprofloxacin-loaded nano-and microcomposite particles for dry powder inhaler formulations: preparation, in vitro characterisation, and antimicrobial efficacy.
Topal GR; Devrim B; Eryilmaz M; Bozkir A
J Microencapsul; 2018 Sep; 35(6):533-547. PubMed ID: 30213209
[TBL] [Abstract][Full Text] [Related]
24. Fine tuning micellar core-forming block of poly(ethylene glycol)-block-poly(ε-caprolactone) amphiphilic copolymers based on chemical modification for the solubilization and delivery of doxorubicin.
Yan J; Ye Z; Chen M; Liu Z; Xiao Y; Zhang Y; Zhou Y; Tan W; Lang M
Biomacromolecules; 2011 Jul; 12(7):2562-72. PubMed ID: 21598958
[TBL] [Abstract][Full Text] [Related]
25. Solubilization of an amphiphilic drug by poly(ethylene oxide)-block-poly(ester) micelles.
Elhasi S; Astaneh R; Lavasanifar A
Eur J Pharm Biopharm; 2007 Mar; 65(3):406-13. PubMed ID: 17291732
[TBL] [Abstract][Full Text] [Related]
26. Nanoparticle DNA carrier with poly(L-lysine) grafted polysaccharide copolymer and poly(D,L-lactic acid).
Maruyama A; Ishihara T; Kim JS; Kim SW; Akaike T
Bioconjug Chem; 1997; 8(5):735-42. PubMed ID: 9327139
[TBL] [Abstract][Full Text] [Related]
27. Effect of aqueous solubility of grafted moiety on the physicochemical properties of poly(d,l-lactide) (PLA) based nanoparticles.
Essa S; Rabanel JM; Hildgen P
Int J Pharm; 2010 Mar; 388(1-2):263-73. PubMed ID: 20060450
[TBL] [Abstract][Full Text] [Related]
28. Novel composite core-shell nanoparticles as busulfan carriers.
Layre A; Couvreur P; Chacun H; Richard J; Passirani C; Requier D; Benoit JP; Gref R
J Control Release; 2006 Apr; 111(3):271-80. PubMed ID: 16488504
[TBL] [Abstract][Full Text] [Related]
29. Folate-modified lipid-polymer hybrid nanoparticles for targeted paclitaxel delivery.
Zhang L; Zhu D; Dong X; Sun H; Song C; Wang C; Kong D
Int J Nanomedicine; 2015; 10():2101-14. PubMed ID: 25844039
[TBL] [Abstract][Full Text] [Related]
30. Solid-state nanoparticle coated emulsions for encapsulation and improving the chemical stability of all-trans-retinol.
Ghouchi-Eskandar N; Simovic S; Prestidge CA
Int J Pharm; 2012 Feb; 423(2):384-91. PubMed ID: 22210001
[TBL] [Abstract][Full Text] [Related]
31. Biodegradable amphiphilic copolymers based on poly(epsilon-caprolactone)-graft chondroitin sulfate as drug carriers.
Chen AL; Ni HC; Wang LF; Chen JS
Biomacromolecules; 2008 Sep; 9(9):2447-57. PubMed ID: 18662028
[TBL] [Abstract][Full Text] [Related]
32. Poly(epsilon-caprolactone)-poly(ethylene glycol)-poly(epsilon-caprolactone) (PCL-PEG-PCL) nanoparticles for honokiol delivery in vitro.
Gou M; Zheng L; Peng X; Men K; Zheng X; Zeng S; Guo G; Luo F; Zhao X; Chen L; Wei Y; Qian Z
Int J Pharm; 2009 Jun; 375(1-2):170-6. PubMed ID: 19427143
[TBL] [Abstract][Full Text] [Related]
33. In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles.
Letchford K; Liggins R; Wasan KM; Burt H
Eur J Pharm Biopharm; 2009 Feb; 71(2):196-206. PubMed ID: 18762253
[TBL] [Abstract][Full Text] [Related]
34. Influence of diblock copolymer PCL-mPEG and of various iodinated oils on the formulation by the emulsion-solvent diffusion process of radiopaque polymeric nanoparticles.
Hallouard F; Briançon S; Anton N; Li X; Vandamme T; Fessi H
J Pharm Sci; 2013 Nov; 102(11):4150-8. PubMed ID: 24018705
[TBL] [Abstract][Full Text] [Related]
35. All-trans-retinoic acid release from core-shell type nanoparticles of poly(epsilon-caprolactone)/poly(ethylene glycol) diblock copolymer.
Jeong YI; Kang MK; Sun HS; Kang SS; Kim HW; Moon KS; Lee KJ; Kim SH; Jung S
Int J Pharm; 2004 Apr; 273(1-2):95-107. PubMed ID: 15010134
[TBL] [Abstract][Full Text] [Related]
36. Strategies to control the particle size distribution of poly-epsilon-caprolactone nanoparticles for pharmaceutical applications.
Lince F; Marchisio DL; Barresi AA
J Colloid Interface Sci; 2008 Jun; 322(2):505-15. PubMed ID: 18402975
[TBL] [Abstract][Full Text] [Related]
37. Amphiphilic copolymers of epsilon-caprolactone and gamma-substituted epsilon-caprolactone. Synthesis and functionalization of poly(D,L-lactide) nanoparticles.
Gautier S; D'Aloia V; Halleux O; Mazza M; Lecomte P; Jérôme R
J Biomater Sci Polym Ed; 2003; 14(1):63-85. PubMed ID: 12635771
[TBL] [Abstract][Full Text] [Related]
38. Poly(ethyleneglycol)-b-poly(ε-caprolactone-co-γ-hydroxyl-ε- caprolactone) bearing pendant hydroxyl groups as nanocarriers for doxorubicin delivery.
Chang L; Deng L; Wang W; Lv Z; Hu F; Dong A; Zhang J
Biomacromolecules; 2012 Oct; 13(10):3301-10. PubMed ID: 22931197
[TBL] [Abstract][Full Text] [Related]
39. Characteristics and release profiles of MPEG-PCL-MPEG microspheres containing immunoglobulin G.
Erdemli Ö; Usanmaz A; Keskin D; Tezcaner A
Colloids Surf B Biointerfaces; 2014 May; 117():487-96. PubMed ID: 24530344
[TBL] [Abstract][Full Text] [Related]
40. Self-aggregation of cationically modified poly(ε-caprolactone)
Charoongchit P; Suksiriworapong J; Sripha K; Mao S; Sapin-Minet A; Maincent P; Junyaprasert VB
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():444-455. PubMed ID: 28024608
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
